Site Navigation

Site Mobile Navigation

Corrections

An article in Business Day on Thursday about the appointment of Karen L. Katen as president of the United States pharmaceutical unit of Pfizer Inc. misspelled the surname of another top woman executive in the pharmaceutical industry, the vice president and general counsel of Eli Lilly & Company. She is Rebecca O. Goss, not Gross.

We are continually improving the quality of our text archives. Please send feedback, error reports,
and suggestions to archive_feedback@nytimes.com.